Bluejay Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
San Francisco, California, United StatesWebsite
www.bluejaytx.comRevenue
$8.2 MillionIndustry
About Bluejay Therapeutics
Bluejay Therapeutics Org Chart
Is Bluejay Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Bluejay Therapeutics launches new products
Click to see if Bluejay Therapeutics had a recent Job posting/layoffs
Check out if Bluejay Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Bluejay Therapeutics
Bluejay Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Bluejay Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Bluejay Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Bluejay Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Bluejay Therapeutics
Compare insights from companies similar to Bluejay Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bluejay Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bluejay Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bluejay Therapeutics.
Bluejay Therapeutics financials insights
Gather financial insights about Bluejay Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series C
$182M
Bluejay Therapeutics Tech Stack
A closer look at the technologies used by Bluejay Therapeutics
Most Recent Scoops
Bluejay Therapeutics News & Media
BioMarin Expands Rare Disease Portfolio With $4.8 Billion Amicus Acquisition
The Healthcare Technology Report is your comprehensive source for business news, investment activity and corporate actions related to the software and SaaS sectorsMirum gains a hepatitis D drug in $620M buyout of startup Bluejay | BioPharma Dive
The deal, which includes another $200 million in potential payouts, hands the California biotech a candidate in late-stage testing for the most severe form of viral hepatitis.Latham Advises Bluejay Therapeutics Acquisition Mirum Pharmaceuticals
Multidisciplinary team represents the biotechnology company in the transaction.Bluejay Therapeutics’ Brelovitug (BJT-778) Monotherapy Achieved 100% Virologic Response and up to 82% Combined Endpoint of Virologic Response and ALT Normalization at Week 48 in Phase 2 Study in Chronic Hepatitis D (CHD)
Bluejay Therapeutics today announced Week 48 treatment data in chronic hepatitis D (CHD) for brelovitug (BJT-778) at AASLD 2025.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bluejay Therapeutics
Based in San Francisco, California, Bluejay Therapeutics is a novel therapeutic development company.... Read More
